Elson So, M.D., of Mayo Clinic College of Medicine
Elected President of the American Epilepsy Society
Washington, D.C., December 9, 2013 – Elson So, M.D., Professor of Neurology and Director of the Section of Electroencephalography at the Mayo Clinic College of Medicine, Rochester, MN, was elected president of the American Epilepsy Society (AES) over the weekend during the organization’s 67th annual meeting at the Washington Convention Center. He succeeds Jacqueline A. French, M.D., who has completed her term.
AES is the 3,000-member society of physicians, scientists and allied healthcare professionals dedicated to the prevention, treatment and cure of epilepsy.
Dr. So serves on the editorial boards of the journals Epilepsia, Epilepsy Research, and Journal of Clinical Neurophysiology. He has served on the Board of Directors of the American Epilepsy Society, the Council of the American Clinical Neurophysiology Society, and The Epilepsy Foundation (EF). He was a member of the Governance Committee and Conflict of Interest Committee of the AES Board of Directors, and recently served as First Vice President of the AES Board. He is a past chair of the Section of Clinical Neurophysiology of the American Academy of Neurology (AAN).
Dr. So has directed educational courses, symposiums, and plenary sessions at the American Academy of Neurology, American Epilepsy Society, American Clinical Neurophysiology Society, and Organization for Human Brain Mapping. He co-chaired the joint AES-EF SUDEP Task Force, and the National Institute of Neurological Disorders and Stroke (NINDS) Workshop on SUDEP. His research interests are in advanced SPECT imaging, SUDEP, and the natural history, treatment outcomes and electro-clinical aspects of intractable epilepsy. He is a named inventor of the Office of Intellectual Property of the Mayo Clinic.
The epilepsies affect 50 million people worldwide, including three million in the United States. The disorder can have a single specific, well-defined cause, such as a head injury, or manifest as a syndrome with a complex of symptoms. It is the third most common neurological disorder after Alzheimer’s disease and stroke.
Media Contact: Natalie Judd cell: 203-605-9515, office: 203-389-5223 firstname.lastname@example.org